Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect Site Concentration of Remifentanil for Conscious Sedation During Awake Nasotracheal Fiberoptic Intubation

NCT01052324 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT01052324
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01052324 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect Site Concentration of Remifentanil for Conscious Sedation During Awake Nasotracheal Fiberoptic Intubation
Lead sponsor
Yonsei University
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2010
Completion date
November 30, 2010
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical disc herniation, cervical spinal stenosis, cervical spine damage